Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7489 | 1282 | 24.7 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
597 | 13382 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATOBLASTOMA | Author keyword | 434 | 64% | 33% | 428 |
2 | MESENCHYMAL HAMARTOMA | Author keyword | 71 | 69% | 5% | 61 |
3 | UNDIFFERENTIATED EMBRYONAL SARCOMA | Author keyword | 65 | 93% | 2% | 25 |
4 | EMBRYONAL SARCOMA | Author keyword | 47 | 88% | 2% | 22 |
5 | HEPATIC MESENCHYMAL HAMARTOMA | Author keyword | 24 | 91% | 1% | 10 |
6 | PEDIATRIC LIVER TUMORS | Author keyword | 15 | 82% | 1% | 9 |
7 | BILIARY RHABDOMYOSARCOMA | Author keyword | 14 | 100% | 1% | 7 |
8 | ADULT HEPATOBLASTOMA | Author keyword | 8 | 100% | 0% | 5 |
9 | UNDIFFERENTIATED SARCOMA OF THE LIVER | Author keyword | 8 | 100% | 0% | 5 |
10 | UNDIFFERENTIATED EMBRYONAL SARCOMA OF THE LIVER | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHILDHOOD HEPATOBLASTOMA | 255 | 89% | 9% | 115 |
2 | UNRESECTABLE HEPATOBLASTOMA | 132 | 94% | 4% | 47 |
3 | METASTATIC HEPATOBLASTOMA | 130 | 95% | 3% | 42 |
4 | UNDIFFERENTIATED EMBRYONAL SARCOMA | 74 | 67% | 5% | 66 |
5 | PEDIATRIC LIVER TUMOR | 69 | 91% | 2% | 29 |
6 | INFUSION DOXORUBICIN | 55 | 87% | 2% | 27 |
7 | PRETREATMENT PROGNOSTIC FACTORS | 50 | 72% | 3% | 39 |
8 | HEPATOBLASTOMA | 45 | 35% | 8% | 106 |
9 | STUDY GROUP SIOPEL 1 | 42 | 94% | 1% | 15 |
10 | MESENCHYMAL HAMARTOMA | 32 | 52% | 3% | 44 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation | 2014 | 4 | 28 | 96% |
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy | 2014 | 4 | 54 | 80% |
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group | 2007 | 60 | 15 | 73% |
Hepatoblastoma clinical research: Lessons learned and future challenges | 2012 | 10 | 18 | 94% |
Chemotherapeutic approaches for newly diagnosed hepatoblastoma: Past, present, and future strategies | 2012 | 9 | 17 | 100% |
Where do we stand with hepatoblastoma? | 2003 | 69 | 88 | 77% |
Undifferentiated embryonal sarcoma of the liver in a child: A case report and review of the literature | 2013 | 3 | 8 | 100% |
Progress in the surgical treatment of malignant liver tumors in children | 2010 | 20 | 48 | 67% |
Surgical treatment of hepatoblastoma | 2012 | 9 | 51 | 88% |
Tumors of the liver in children | 2007 | 66 | 47 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SURG UROL CHILDREN ADOLESCENTS | 2 | 25% | 0.5% | 7 |
2 | CHILD ECOL | 1 | 31% | 0.3% | 4 |
3 | NO YORKSHIRE CLIN TRIAL UNIT | 1 | 100% | 0.2% | 2 |
4 | PAEDIAT SURG LIVER TRANSPLANTAT | 1 | 100% | 0.2% | 2 |
5 | PEDIAT CYTOGENET | 1 | 40% | 0.2% | 2 |
6 | PEDIAT GASTROENTEROL ONCOL | 1 | 33% | 0.2% | 2 |
7 | ANATOMO PATHOL UNIT | 1 | 50% | 0.1% | 1 |
8 | BAYSTATE MED PEDIAT SURG | 1 | 50% | 0.1% | 1 |
9 | CELL THER Y TRANSPLANT MED | 1 | 50% | 0.1% | 1 |
10 | CHIEF PEDIAT SURG | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000086713 | FIBROLAMELLAR HEPATOCELLULAR CARCINOMA//FIBROLAMELLAR CARCINOMA//COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA |
2 | 0.0000081976 | MOUSE HEPATOCARCINOGENESIS//METABOLIC ZONATION//EXPT PATHOL EP |
3 | 0.0000058901 | FOCAL NODULAR HYPERPLASIA//HEPATOCELLULAR ADENOMA//HEPATIC ADENOMA |
4 | 0.0000056194 | INFANTILE HEMANGIOMA//KAPOSIFORM HEMANGIOENDOTHELIOMA//KASABACH MERRITT SYNDROME |
5 | 0.0000056105 | PRIMARY HEPATIC CARCINOID TUMOR//PRIMARY HEPATIC NEUROENDOCRINE TUMOR//LIVER CARCINOID |
6 | 0.0000053696 | THOROTRAST//LIVER ANGIOSARCOMA//VINYL CHLORIDE MONOMER |
7 | 0.0000040751 | TRISOMY 18//TRISOMY 13//PATAU SYNDROME |
8 | 0.0000036996 | WEISMANN NETTER STUHL SYNDROME//GLOMERULOCYSTIC KIDNEY//GLOMERULOCYSTIC KIDNEY DISEASE |
9 | 0.0000033562 | SARCOMATOID CARCINOMA//CARCINOSARCOMA//PULMONARY CARCINOSARCOMA |
10 | 0.0000033380 | PERIHEPATIC LYMPH NODE ENLARGEMENT//PERIPORTAL EDEMA//PERIHEPATIC LYMPHADENOPATHY |